Loading...

Recursion Pharmaceuticals, Inc. Peer Comparison

Metric Value Ranking
Market Cap $3.2 Billion 1/18 RXRX
$3.2B
DAWN
$1.2B
SANA
$634.1M
RLAY
$629.4M
ABSI
$573.1M
INZY
$86.7M
ABOS
$82.3M
XFOR
$80.2M
IMMX
$54.7M
FRLN
$28.3M
AFMD
$15.2M
OCEA
$5.9M
CNSP
$5.7M
AVRO
$5.2M
ENVB
$3.0M
HEPA
$2.1M
CWBR
$1.2M
EFTR
$0
Gross Margin 54% 5/18 AFMD
100%
FRLN
100%
ABSI
100%
DAWN
92%
RXRX
54%
XFOR
18%
CWBR
0%
AVRO
0%
HEPA
0%
CNSP
0%
RLAY
0%
INZY
0%
SANA
0%
OCEA
0%
EFTR
0%
ENVB
0%
ABOS
0%
IMMX
0%
Profit Margin -100% 15/18 XFOR
100%
DAWN
100%
CWBR
0%
AVRO
0%
HEPA
0%
CNSP
0%
RLAY
0%
INZY
0%
SANA
0%
OCEA
0%
EFTR
0%
ENVB
0%
ABOS
0%
IMMX
0%
RXRX
-100%
AFMD
-100%
FRLN
-100%
ABSI
-100%
EBITDA margin -377% 14/18 DAWN
148%
CWBR
-100%
AVRO
-100%
HEPA
-100%
CNSP
-100%
RLAY
-100%
INZY
-100%
SANA
-100%
OCEA
-100%
EFTR
-100%
ENVB
-100%
ABOS
-100%
IMMX
-100%
RXRX
-377%
ABSI
-1404%
XFOR
-5986%
AFMD
-9320%
FRLN
-231180%
Quarterly Revenue $26.1 Million 1/18 RXRX
$26.1M
DAWN
$20.1M
ABSI
$1.7M
XFOR
$563,000
AFMD
$170,330
FRLN
$5,000
CWBR
$0
AVRO
$0
HEPA
$0
CNSP
$0
RLAY
$0
INZY
$0
SANA
$0
OCEA
$0
EFTR
$0
ENVB
$0
ABOS
$0
IMMX
$0
Quarterly Earnings -$95.7 Million 18/18 XFOR
$90.8M
DAWN
$37.0M
ENVB
-$2.1M
CWBR
-$4.3M
HEPA
-$4.9M
OCEA
-$5.5M
CNSP
-$5.6M
AVRO
-$6.8M
IMMX
-$7.1M
EFTR
-$8.8M
FRLN
-$12.1M
AFMD
-$16.6M
INZY
-$24.6M
ABSI
-$27.4M
ABOS
-$29.8M
SANA
-$59.9M
RLAY
-$88.1M
RXRX
-$95.7M
Quarterly Free Cash Flow -$60.8 Million 17/18 OCEA
-$885,000
ENVB
-$927,073
CWBR
-$1.8M
HEPA
-$2.5M
IMMX
-$4.3M
DAWN
-$5.0M
CNSP
-$6.8M
EFTR
-$7.3M
AVRO
-$7.6M
FRLN
-$8.7M
AFMD
-$12.2M
ABSI
-$20.8M
INZY
-$24.5M
ABOS
-$24.6M
XFOR
-$30.4M
SANA
-$55.9M
RXRX
-$60.8M
RLAY
-$75.3M
Trailing 4 Quarters Revenue $65.2 Million 1/18 RXRX
$65.2M
DAWN
$28.8M
RLAY
$10.0M
ABSI
$4.2M
AFMD
$963,736
FRLN
$622,000
XFOR
$563,000
CWBR
$0
AVRO
$0
HEPA
$0
CNSP
$0
INZY
$0
SANA
$0
OCEA
$0
EFTR
$0
ENVB
$0
ABOS
$0
IMMX
$0
Trailing 4 Quarters Earnings -$377.6 Million 18/18 RXRX
$26.1M
DAWN
$20.1M
ABSI
$1.7M
XFOR
$563,000
AFMD
$170,330
FRLN
$5,000
CWBR
-$0
AVRO
-$0
HEPA
-$0
CNSP
-$0
RLAY
-$0
INZY
-$0
SANA
-$0
OCEA
-$0
EFTR
-$0
ENVB
-$0
ABOS
-$0
IMMX
-$0
Quarterly Earnings Growth -3% 10/18 XFOR
263%
DAWN
180%
AVRO
72%
OCEA
61%
HEPA
54%
AFMD
38%
ENVB
26%
FRLN
19%
EFTR
10%
RXRX
-3%
CNSP
-24%
ABSI
-25%
RLAY
-34%
INZY
-48%
CWBR
-59%
IMMX
-67%
ABOS
-130%
SANA
-6190%
Annual Earnings Growth -17% 14/18 XFOR
108%
HEPA
57%
ENVB
55%
OCEA
50%
DAWN
50%
FRLN
43%
AFMD
38%
ABSI
34%
EFTR
12%
SANA
10%
RLAY
4%
CWBR
1%
CNSP
-3%
RXRX
-17%
IMMX
-46%
INZY
-52%
AVRO
-59%
ABOS
-71%
Quarterly Revenue Growth 158% 1/18 RXRX
158%
ABSI
129%
CWBR
0%
AVRO
0%
HEPA
0%
XFOR
0%
CNSP
0%
INZY
0%
FRLN
0%
SANA
0%
OCEA
0%
DAWN
0%
EFTR
0%
ENVB
0%
ABOS
0%
IMMX
0%
AFMD
-92%
RLAY
-100%
Annual Revenue Growth 51% 1/18 RXRX
51%
CWBR
0%
AVRO
0%
HEPA
0%
XFOR
0%
CNSP
0%
INZY
0%
FRLN
0%
SANA
0%
OCEA
0%
DAWN
0%
EFTR
0%
ENVB
0%
ABOS
0%
IMMX
0%
RLAY
-61%
ABSI
-61%
AFMD
-86%
Cash On Hand $427.6 Million 1/18 RXRX
$427.6M
DAWN
$422.8M
RLAY
$152.4M
XFOR
$147.2M
SANA
$127.0M
AVRO
$90.8M
ABSI
$38.2M
ABOS
$33.2M
FRLN
$29.5M
INZY
$24.6M
IMMX
$19.7M
EFTR
$15.5M
AFMD
$8.1M
CNSP
$7.0M
CWBR
$6.2M
ENVB
$3.1M
HEPA
$1.5M
OCEA
-$0
Short Term Debt $16.5 Million 2/18 EFTR
$19.0M
RXRX
$16.5M
OCEA
$12.8M
SANA
$10.6M
AFMD
$7.6M
RLAY
$5.5M
ABSI
$5.0M
INZY
$4.6M
FRLN
$2.3M
HEPA
$2.2M
XFOR
$1.2M
AVRO
$224,000
ABOS
$129,000
DAWN
$77,000
IMMX
$62,715
CNSP
$31,187
CWBR
-$0
ENVB
-$0
Long Term Debt $74.2 Million 3/18 SANA
$85.5M
XFOR
$75.0M
RXRX
$74.2M
RLAY
$44.3M
INZY
$42.2M
ABOS
$29.9M
ABSI
$7.0M
AFMD
$6.6M
DAWN
$2.5M
FRLN
$1.7M
IMMX
$1.0M
EFTR
$179,000
CWBR
$0
AVRO
$0
HEPA
$0
CNSP
$0
OCEA
$0
ENVB
$0
PE -1.00 3/18 XFOR
4.55
AVRO
0.17
RXRX
-1.00
AFMD
-1.00
CWBR
-1.00
HEPA
-1.00
CNSP
-1.00
RLAY
-1.00
INZY
-1.00
FRLN
-1.00
SANA
-1.00
OCEA
-1.00
DAWN
-1.00
EFTR
-1.00
ENVB
-1.00
ABOS
-1.00
ABSI
-1.00
IMMX
-1.00
PS 49.10 4/18 XFOR
142.37
ABSI
136.23
RLAY
62.90
RXRX
49.10
FRLN
45.47
DAWN
42.44
AFMD
14.38
CWBR
-1.00
AVRO
-1.00
HEPA
-1.00
CNSP
-1.00
INZY
-1.00
SANA
-1.00
OCEA
-1.00
EFTR
-1.00
ENVB
-1.00
ABOS
-1.00
IMMX
-1.00
PB 6.10 1/18 RXRX
6.10
IMMX
3.12
ABSI
2.85
DAWN
2.20
SANA
2.17
CNSP
1.71
INZY
1.05
FRLN
0.94
XFOR
0.85
AFMD
0.81
ENVB
0.77
RLAY
0.75
ABOS
0.38
CWBR
0.13
AVRO
0.06
HEPA
0.00
OCEA
0.00
EFTR
0.00
PC 7.48 2/18 ABSI
15.01
RXRX
7.48
SANA
4.99
RLAY
4.13
INZY
3.53
DAWN
2.89
IMMX
2.78
ABOS
2.48
AFMD
1.87
HEPA
1.42
ENVB
0.98
FRLN
0.96
CNSP
0.82
XFOR
0.54
CWBR
0.19
AVRO
0.06
EFTR
0.00
OCEA
-1.00
Liabilities to Equity 0.38 9/18 EFTR
31.81
AFMD
1.32
XFOR
1.23
CNSP
1.21
SANA
0.91
INZY
0.73
FRLN
0.64
IMMX
0.43
RXRX
0.38
CWBR
0.32
ABOS
0.23
ENVB
0.21
ABSI
0.17
RLAY
0.11
DAWN
0.08
AVRO
0.04
HEPA
0.00
OCEA
0.00
ROA -0.52 7/18 AVRO
33%
XFOR
8%
DAWN
-15%
ABOS
-31%
RLAY
-37%
ABSI
-42%
RXRX
-52%
SANA
-55%
INZY
-67%
IMMX
-87%
CWBR
-99%
FRLN
-101%
EFTR
-128%
AFMD
-192%
ENVB
-206%
CNSP
-230%
HEPA
-611%
OCEA
-2352%
ROE -0.72 9/18 HEPA
5583%
AVRO
34%
OCEA
27%
XFOR
19%
DAWN
-16%
ABOS
-38%
RLAY
-41%
ABSI
-49%
RXRX
-72%
SANA
-105%
INZY
-117%
IMMX
-125%
CWBR
-131%
FRLN
-166%
ENVB
-249%
AFMD
-447%
CNSP
-509%
EFTR
-4187%
Current Ratio 3.60 8/18 AVRO
26.32
DAWN
13.25
RLAY
10.19
ABSI
6.94
ENVB
5.71
ABOS
5.36
CWBR
4.17
RXRX
3.60
IMMX
3.31
FRLN
2.57
INZY
2.37
SANA
2.10
CNSP
1.83
XFOR
1.81
AFMD
1.76
EFTR
1.03
HEPA
0.90
OCEA
0.01
Quick Ratio 2.12 9/18 XFOR
4.55
AVRO
0.17
RXRX
-1.00
AFMD
-1.00
CWBR
-1.00
HEPA
-1.00
CNSP
-1.00
RLAY
-1.00
INZY
-1.00
FRLN
-1.00
SANA
-1.00
OCEA
-1.00
DAWN
-1.00
EFTR
-1.00
ENVB
-1.00
ABOS
-1.00
ABSI
-1.00
IMMX
-1.00
Long Term Debt to Equity 0.14 6/18 XFOR}
0.79
INZY}
0.51
AFMD}
0.35
SANA}
0.29
EFTR}
0.22
RXRX}
0.14
ABOS}
0.14
FRLN}
0.06
IMMX}
0.06
RLAY}
0.05
ABSI}
0.03
CWBR}
0.00
AVRO}
0.00
HEPA}
0.00
CNSP}
0.00
OCEA}
0.00
DAWN}
0.00
ENVB}
0.00
Debt to Equity 0.17 6/18 EFTR
23.15
XFOR
0.83
AFMD
0.75
INZY
0.57
SANA
0.33
RXRX
0.17
ABOS
0.14
FRLN
0.13
RLAY
0.06
ABSI
0.06
IMMX
0.06
CNSP
0.01
CWBR
0.00
AVRO
0.00
DAWN
0.00
ENVB
0.00
OCEA
-0.13
HEPA
-5.47
Burn Rate 4.16 2/18 AVRO
13.22
RXRX
4.16
IMMX
2.73
FRLN
2.31
SANA
1.92
RLAY
1.67
ENVB
1.49
CWBR
1.43
ABSI
1.32
CNSP
1.24
EFTR
1.14
ABOS
1.07
INZY
0.90
AFMD
0.40
HEPA
0.28
OCEA
0.00
XFOR
-1.68
DAWN
-11.45
Cash to Cap 0.13 15/18 AVRO
17.33
CWBR
5.20
XFOR
1.84
CNSP
1.21
FRLN
1.04
ENVB
1.02
HEPA
0.70
AFMD
0.53
ABOS
0.40
IMMX
0.36
DAWN
0.35
INZY
0.28
RLAY
0.24
SANA
0.20
RXRX
0.13
ABSI
0.07
OCEA
0.00
EFTR
CCR 0.64 11/18 CNSP
1.21
AVRO
1.11
INZY
1.00
SANA
0.93
RLAY
0.85
ABOS
0.83
EFTR
0.82
ABSI
0.76
AFMD
0.74
FRLN
0.72
RXRX
0.64
IMMX
0.60
HEPA
0.52
ENVB
0.44
CWBR
0.42
OCEA
0.16
DAWN
-0.13
XFOR
-0.33
EV to EBITDA -29.11 18/18 DAWN}
27.10
FRLN}
-0.24
XFOR}
-0.33
CWBR}
-1.00
AVRO}
-1.00
HEPA}
-1.00
CNSP}
-1.00
INZY}
-1.00
SANA}
-1.00
OCEA}
-1.00
EFTR}
-1.00
ENVB}
-1.00
ABOS}
-1.00
IMMX}
-1.00
AFMD}
-1.54
RLAY}
-5.47
ABSI}
-22.91
RXRX}
-29.11
EV to Revenue 43.93 3/18 ABSI
130.00
RLAY
52.65
RXRX
43.93
DAWN
27.86
AFMD
23.05
XFOR
19.83
FRLN
4.53
CWBR
-1.00
AVRO
-1.00
HEPA
-1.00
CNSP
-1.00
INZY
-1.00
SANA
-1.00
OCEA
-1.00
EFTR
-1.00
ENVB
-1.00
ABOS
-1.00
IMMX
-1.00